Gut microbial variation may predict neonatal jaundice. human gut metagenome

Neonatal jaundice is a common disease that affects up to 60% of newborns and there are few available diagnostic biomarkers clinically for neonatal jaundice. This study aims to characterize gut microbiome in neonatal jaundice and explore potential of microbiome as a biomarker for neonatal jaundice.

新生儿黄疸（Neonatal jaundice）是一种常见新生儿疾病，在新生儿中的患病率高达60%，目前临床可供使用的该病诊断生物标志物（biomarker）较为匮乏。本研究旨在阐明新生儿黄疸患儿的肠道微生物组（gut microbiome）特征，并探讨菌群作为新生儿黄疸诊断生物标志物的潜在应用价值。